Briefing

Industry news

Industry briefing

Covid-19 briefing

NEWS

FDA expands EUA of Pfizer-BioNTech’s Covid-19 booster shot to adolescents

BRIEFING

Merck’s Molnupiravir gains FDA EUA

The US FDA granted an EUA for Merck-Ridgeback’s oral Covid-19 antiviral molnupiravir based on positive results from the Phase III MOVe-OUT trial

covid-19

Global economy growth projected at 5.9% for last year

GDP estimates for many countries have turned positive and the global economy is projected to grow 5.9 percent in 2021

Industry news

Industry briefing

Covid-19 briefing

02/24/2024 13:50:16
  • Home | Mapping the RNA therapeutics R&D landscape in 2022 
  • In this issue
  • Contents
  • CSafe Global
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • HOF Sonderanlagenbau
  • BEA Technologies
  • Comment
  • Restrictive Medicare coverage spells continued uncertainty for Aduhelm
  • 2021: a record year for orphan therapies
  • Trikafta/Kaftrio continues to be a game-changer for cystic fibrosis patients
  • Mimotopes Company Insight
  • Mimotopes
  • In Depth
  • Mapping the RNA therapeutics R&D landscape in 2022
  • A cloudy day in paradise for pharma tax havens in Cayman Islands & Bermuda?
  • Pharmaceutical Technology Excellence Awards 2021 – Winners Announced!
  • How technology could transform drug research in 2022
  • Anaesthesia drugs worst-hit by US drug shortages
  • Molnar-Institute Company Insight
  • Molnar-Institute
  • In Data
  • Asia-Pacific sees the largest growth in metabolic disorders-related trials over
  • The Middle East has seen the largest growth in infectious disease-related trials over the past decade
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Baxter
  • Events
  • Next issue
01/20/2022 00:00:00